Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Sep 26, 2007 at 1:12 PM EDT

Cephalon’s FDA Warning More of a Formality (CEPH)

Cephalon Inc. (NASDAQ:CEPH) is a biotech that has been under a bit of a low ceiling after its recent blunder…

Douglas A. McIntyre | Sep 24, 2007 at 8:37 AM EDT

Sonus (SNUS) Gets Slaughtered

Sonus Pharmaceuticals (SNUS) said that its drug candidate Tocosol Paclitaxel failed in a late-stage study aimed at treating breast cancer,…

Douglas A. McIntyre | Sep 21, 2007 at 1:27 PM EDT

IPO FILING: EMPHASYS MEDICAL, INC. (EMPH)

EMPHASYS MEDICAL, INC. has filed to come public via an initial public offering and has listed it initial sale of…

Douglas A. McIntyre | Sep 19, 2007 at 3:52 PM EDT

BioCryst Botched Flu Results (BCRX)

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has announced preliminary findings from a Phase II study with intramuscular injection of Peramivir, the…

Douglas A. McIntyre | Sep 19, 2007 at 8:25 AM EDT

IPO Filing: MAKO Surgical Corp.

MAKO Surgical Corp. has filed to come public in an initial public offering and for nominal filing purposes, it lists…

Douglas A. McIntyre | Sep 17, 2007 at 4:59 AM EDT

Food Makers Ask FDA For More Regulation: Target China

The Grocery Manufacturers Association is going to ask the government to strengthen regulation of food imports. The group, which includes…

Douglas A. McIntyre | Sep 16, 2007 at 4:11 PM EDT

More Tainted Products From China, Drugs This Time

The Chinese are now poisoning their own population. With any luck, a new case of tainted drugs found in the…

Douglas A. McIntyre | Sep 13, 2007 at 7:32 AM EDT

ISIS Scores On J&J Collaboration & Milestones (ISIS, JNJ)

ISIS Pharmaceuticals Inc. (NASDAQ:ISIS) is trading up pre-market on new that it entered a broad collaboration with Ortho-McNeil, a Johnson…

Douglas A. McIntyre | Sep 12, 2007 at 8:44 AM EDT

Cardica Trumps Wall St.

Shares in Cardica (CRDC) fell of a cliff yesterday as an A.G. Edwards analyst downgraded the stock on muted enthusiasm…

Douglas A. McIntyre | Sep 12, 2007 at 7:25 AM EDT

Amgen Set To Run (AMGN, JNJ, BIIB)

Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday’s decision where an FDA panel rejected a…

Douglas A. McIntyre | Sep 12, 2007 at 4:56 AM EDT

GlaxoSmithKline Continues Down A Dangerous Path

Two more studies show that GlaxoSmithKline (GSK) blockbuster diabetes drug Avandia has significant health risks. According to The Wall Street…

Douglas A. McIntyre | Sep 11, 2007 at 10:24 AM EDT

Institutional Buyer Sheds Light on Dendreon (DNDN)

An interesting event happened yesterday in the form of an SEC Filing on Dendreon (NASDAQ:DNDN) that ran the stock. In…

Douglas A. McIntyre | Sep 11, 2007 at 7:44 AM EDT

Amgen: Today’s Review Critical For Anemia Reimbursements (AMGN)

Amgen (NASDAQ:AMGN) has a huge day ahead of it. The biotech giant is presenting data today on the appropriateuse of…

Douglas A. McIntyre | Sep 11, 2007 at 7:22 AM EDT

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

Shares of Imclone Systems Inc. (NASDAQ:IMCL) are screaming higher this morning on it meeting its primary endpoint of increasing survival…

Douglas A. McIntyre | Sep 11, 2007 at 4:56 AM EDT

A Black Eye For Biofuels

All those "green" people out there may want to take into consideration the fact that biofuels are unlikely to have…

1 … 364 365 366 367 368 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Cephalon’s FDA Warning More of a Formality (CEPH)

Sonus (SNUS) Gets Slaughtered

IPO FILING: EMPHASYS MEDICAL, INC. (EMPH)

BioCryst Botched Flu Results (BCRX)

IPO Filing: MAKO Surgical Corp.

Food Makers Ask FDA For More Regulation: Target China

More Tainted Products From China, Drugs This Time

ISIS Scores On J&J Collaboration & Milestones (ISIS, JNJ)

Cardica Trumps Wall St.

Amgen Set To Run (AMGN, JNJ, BIIB)

GlaxoSmithKline Continues Down A Dangerous Path

Institutional Buyer Sheds Light on Dendreon (DNDN)

Amgen: Today’s Review Critical For Anemia Reimbursements (AMGN)

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

A Black Eye For Biofuels

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Health and Healthcare Articles

All Health and Healthcare Articles

Cephalon’s FDA Warning More of a Formality (CEPH)

Sonus (SNUS) Gets Slaughtered

IPO FILING: EMPHASYS MEDICAL, INC. (EMPH)

BioCryst Botched Flu Results (BCRX)

IPO Filing: MAKO Surgical Corp.

Food Makers Ask FDA For More Regulation: Target China

More Tainted Products From China, Drugs This Time

ISIS Scores On J&J Collaboration & Milestones (ISIS, JNJ)

Cardica Trumps Wall St.

Amgen Set To Run (AMGN, JNJ, BIIB)

GlaxoSmithKline Continues Down A Dangerous Path

Institutional Buyer Sheds Light on Dendreon (DNDN)

Amgen: Today’s Review Critical For Anemia Reimbursements (AMGN)

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

A Black Eye For Biofuels

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%